Submissions

Original articles

ORIGINAL ARTICLE

Scope and General Considerations

All manuscripts submitted to Revista Alergia México must adhere to international editorial, methodological, and ethical standards. These guidelines apply to all sections of the journal.

Original Articles

Original articles present the results of clinical, epidemiological, or basic research that contribute new scientific knowledge in the fields of allergy, immunology, and related disciplines. These studies must be based on rigorous methodology and comply with ethical and editorial best practices.

Article Structure

Title Page

• Mandatory for all submissions.

Authors

• Listed in order of contribution.
• Include full academic or professional affiliation for each author.
• Provide the ORCID iD for each author.

Abstract

• Required in both Spanish and English.
• Maximum length: 250 words per language.
• Structured format: Background, Objectives, Methods, Results, and Conclusion.

Keywords

• Include 3 to 5 keywords in both Spanish and English.
• Must align with Medical Subject Headings (MeSH) terms.

Main Text

• Maximum length: 2,500 words (from Introduction to Conclusion).
• Introduction: Clearly define the study’s objectives at the end of this section.
• Methods: Describe statistical analyses at the end of this section.
• Results
• Discussion
• Conclusions
• Acknowledgments (if applicable).
• Conflicts of Interest Statement
• Funding Statement
• Ethical Responsibilities:
• Studies involving human subjects must adhere to international ethical standards, including the Declaration of Helsinki (https://www.wma.net/what-we-do/medical-ethics/declaration-of-helsinki/).
• Revista Alergia México follows the ethical guidelines of the Committee on Publication Ethics (COPE) (https://publicationethics.org/).
• Authors must provide the approval number from the institutional research ethics committee.

References

• Preferably from the last 10 years.
• Must follow the AMA citation format.

Tables and Figures

• Maximum of 6 tables and figures combined.
• Submit as separate, editable files (JPG, TIF).
• Numbered with Arabic numerals.
• Minimum resolution: 300 ppi.

Figures, Graphs, and Images

• Maximum of 6.
• Submit as separate, editable files (TIFF, JPG, PNG).
• Numbered with Arabic numerals.
• Minimum resolution: 300 ppi.

List of Abbreviations

• Include if necessary.

Review articles

REVIEW ARTICLES

Review articles submitted  of Revista Alergia México must adhere to international editorial and methodological standards. Authors are encouraged to use systematic review and meta-analysis guidelines such as PRISMA (PRISMA 2020) or similar resources available from EQUATOR Network.

Articles that do not comply with these guidelines will not be considered for the editorial process.

Article Structure

Title Page

• Required.

Authors

• Listed in order of contribution.
• Include full academic or professional affiliation for each author.
• Provide the ORCID iD for each author.

Abstract

• Must be provided in both Spanish and English.

• Maximum length: 250 words per language.

• Unstructured.

Keywords

• Between 3 and 5.

• Must align with MESH terms.

• Provided in both Spanish and English.

Main Text

• Maximum length: 2500 words (from Introduction to Conclusion).

• Introduction: Objectives must be included at the end of this section.

• Methods: Describe bibliographic search sources (databases, keywords, search periods, and limits), as well as any unconventional methods used (manual searches, personal communications, etc.).

• Conclusions.

• Acknowledgments.

• Conflict of Interest Statements.

• Funding.

References

• Between 25 and 75.

• No older than 10 years.

• AMA format.

Tables and Charts

• Maximum of 6.

• Submitted as separate files in an editable format.

• Numbered with Arabic numerals.

Figures, Graphs, and Images

• Maximum of 6.

• Submitted as separate files in an editable format.

• Numbered with Arabic numerals.

• Minimum resolution: 300 ppi.

• Format: TIFF, JPG.

List of Abbreviations

• Included if necessary.

Clinical guidelines

CLINICAL GUIDELINES

Submissions to the CLINICAL GUIDELINES section of Revista Alergia México must adhere to international editorial, methodological, and ethical standards. Authors are strongly encouraged to follow established guidelines for clinical practice and systematic reviews, such as PRISMA 2020 for systematic reviews and meta-analyses (http://www.prisma-statement.org/) or other resources available through the EQUATOR Network (https://www.equator-network.org/).

Manuscripts that do not meet these guidelines may be rejected prior to the peer-review process.

ARTICLE STRUCTURE

Title Page

• Mandatory for all submissions.

Authors

• Authors should be listed in order of contribution.
• Provide the full academic or professional affiliation for each author.
• Include the ORCID iD for each author.
• Conflict of Interest Statement: Each author must submit a conflict of interest disclosure using the form provided by the International Committee of Medical Journal Editors (ICMJE) (https://www.icmje.org/conflicts-of-interest/).

Abstract

• Required in both Spanish and English.
• Maximum length: 250 words per language.
• For clinical guidelines, the abstract should follow a structured format:
  • Background – Provide the context and rationale for the guideline.
  • Objectives – Clearly define the aims of the guideline.
  • Methods – Describe the development process, including the sources of evidence, search strategies, and criteria for inclusion.
  • Recommendations – Summarize key recommendations and their strength of evidence.
  • Conclusions – Highlight the relevance and potential impact on clinical practice.

Keywords

• Include between 3 and 5 keywords in both Spanish and English.
• Keywords must align with Medical Subject Headings (MeSH) terms.

Main Text

The main text should not exceed 2,500 words (excluding references, tables, and figures).

Introduction

• Provide a clear background on the clinical issue or question being addressed.
• State the specific objectives of the guideline at the end of this section.

Methods

• Describe the methodology used to develop the guideline, including:
  • Databases consulted (e.g., PubMed, Scopus).
  • Keywords and search terms used.
  • Search periods and inclusion/exclusion criteria.
  • Levels of evidence and grading of recommendations.
  • Any unconventional methods used (e.g., expert consensus, personal communications).

Recommendations

• Provide clear and actionable recommendations.
• State the strength of each recommendation and the quality of supporting evidence using an established grading system (e.g., GRADE).
• Recommendations should be practical, relevant, and based on the best available evidence.

Discussion

• Discuss the clinical significance and potential limitations of the guideline.
• Compare with existing guidelines or recommendations from other organizations (if applicable).
• Highlight any gaps in knowledge or areas for future research.

Conclusions

• Summarize the key recommendations and their expected impact on clinical practice.

Acknowledgments

• Include if applicable.
• List individuals or institutions that contributed to the development of the guideline but do not meet the criteria for authorship.

Conflict of Interest Statement

• Each author must submit a conflict of interest statement using the ICMJE form.
• Clearly disclose any financial or non-financial conflicts of interest that may have influenced the development of the guideline.

Funding

• Identify any sources of funding or financial support.
• Specify the role of the funding body in the development of the guideline (if applicable).

Ethical Considerations

• Manuscripts must adhere to the ethical guidelines established by the Committee on Publication Ethics (COPE) (https://publicationethics.org).
• If the guideline involves human participants, authors must confirm compliance with the Declaration of Helsinki (https://www.wma.net/).
• If applicable, provide the approval number from the institutional research ethics committee.

References

• Include between 25 and 150 references.
• Preferably from the last 10 years unless citing landmark studies.
• Use the American Medical Association (AMA) citation format.
• Avoid excessive self-citation.

Tables and Charts

• Maximum of 6 tables and charts combined.
• Submit as separate editable files (e.g., Word, Excel).
• Number using Arabic numerals (e.g., Table 1, Table 2).
• Include descriptive titles and footnotes where necessary.

Figures, Graphs, and Images

• Maximum of 6.
• Must be submitted as separate editable files.
• Number using Arabic numerals (e.g., Figure 1, Figure 2).
• Minimum resolution: 300 ppi.
• Acceptable formats: TIFF, JPG, PNG.
• Include detailed legends.

List of Abbreviations

• Include if necessary.
• Define all abbreviations upon first use in the text.

Additional Considerations

• All manuscripts must be submitted electronically through the journal’s submission system.
• The editorial team reserves the right to request modifications to ensure compliance with the journal’s standards.
• Articles that do not meet formatting or content requirements may be returned to the authors for revision before proceeding to the peer-review process.
• Clinical guidelines should reflect current evidence and follow international standards for guideline development and reporting.
• If the guideline updates or replaces a previous publication, clearly state this in the introduction.

Evaluation and Peer Review

• All submitted guidelines undergo double-blind peer review by experts in the field.
• Reviewers evaluate the quality of evidence, clarity of recommendations, and overall relevance to clinical practice.
• Authors are expected to address reviewer comments promptly and thoroughly during the revision process.

Consensus and Position papers

Consensus and Position Papers

1. Scope and Objective

The Consensus and Position Papers section publishes official statements and consensus documents from scientific societies, expert groups, or academic institutions on relevant topics in health and science. These documents must be evidence-based and follow rigorous methodologies for formulating recommendations.

2. General Publication Criteria

• Manuscripts must be original, unpublished, and not under review elsewhere.
• Transparency in the methodology used for consensus or position statements is required.
• Authors must comply with international ethical standards in scientific publishing, including conflict of interest declarations, funding disclosure, and ethical responsibilities.
• It is recommended to follow GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) guidelines and the Delphi methodology or similar consensus approaches.

3. Manuscript Structure

3.1. Title Page (Mandatory)

Must include:

• Document title.

  Authors

  • Listed in order of contribution.
  • Include full academic or professional affiliation for each author.
  • Provide the ORCID iD for each author.
• Contact details of the corresponding author.

3.2. Abstract (Spanish and English, maximum 300 words per language)

• Structured into: Introduction, Objective, Methodology, Key Recommendations, and Conclusion.
• 3 to 6 keywords, aligned with MESH terms.

3.3. Main Text (Maximum 5,000 words, excluding references, tables, and figures)

• Introduction (Context and relevance of the document).
• Methods (Selection criteria for experts, methodology used, and evidence analysis).
• Results or Recommendations (Key findings and proposed guidelines).
• Discussion (Comparison with previous literature and consensus limitations).
• Conclusion (Summary of findings and practical applications).
• Acknowledgments (Optional).
• Conflict of Interest Statement (Mandatory).
• Funding Statement (If applicable).
• Ethical Responsibilities (Include compliance with international standards and ethics committee approval number if applicable).

3.4. References

• Maximum 100 citations.
• No older than 10 years, unless they are key references.
• AMA (American Medical Association) format required.

3.5. Tables and Figures (Maximum 10, submitted as separate editable files)

• Minimum resolution 300 ppi.
• Numbered with Arabic numerals.
• Accepted formats: JPG, TIF, PNG.

3.6. List of Abbreviations (Include at the end if necessary).

4. Submission and Peer Review

• All manuscripts undergo a double-blind peer review process.
• The Editorial Committee may request revisions or reject manuscripts that do not meet the established standards.

Case clinical reports

CASE CLINICAL REPOSTS

The Case Reports section of Revista Alergia México welcomes submissions from all areas of Allergy and Immunology. These reports should provide valuable clinical insights, contribute to medical education, and highlight unique or instructive aspects of patient care.

Submission Criteria

A case report should:

1. Present a clinically relevant case with significant educational value.
2. Illustrate the application of an important clinical guideline or systematic review, specifying the exact aspect of the guideline being highlighted.
3. Offer a clear and practical teaching point, whether related to best practices, medical errors, or new perspectives on disease pathogenesis.
4. Be logically structured, similar to a case discussion between colleagues, ensuring clarity and coherence.
5. Provide sufficient but concise details on patient history, clinical findings, diagnostic workup, and management.
6. Include a clear outcome, avoiding ambiguity about the final patient status.
7. Contextualize the case within existing literature, supporting the discussion with up-to-date references.
8. Be well-written in terms of clarity, style, and use of professional English.

Manuscript Requirements

• Word count: 1,000–3,000 words.
• Key Clinical Message (KCM): A concise 50-word summary of the main takeaway from the case. This replaces the abstract.
• References: Current and relevant to the case.
• Figures & Images: High-quality clinical images (TIFF, JPG; ≥300 dpi) if applicable.
• Units: International System of Units (SI) must be used throughout.
• Authors (full name, institutional affiliation, ORCID ID, and contact email of the corresponding author)

Case Images

Submissions featuring clinical images should:

• Present a key clinical finding that serves as a teaching point.
• Include an accompanying brief text (≤500 words, max. 3 references) describing the clinical relevance.
• Be formatted as a question-answer discussion to enhance educational value.
• Use high-resolution images (TIFF format, ≥300 dpi) to ensure clarity.

For further guidance, authors should refer to the illustration submission guidelines available on our Author Services .

These guidelines apply to all sections of Revista Alergia México where case reports are accepted.

Letters to the editor

Letter to the Editor

1. Scope and Objective The "Letter to the Editor" section aims to provide a space for academic discussion and the exchange of opinions on relevant topics within the journal's scope. Submissions may include comments on published articles, contributions related to ongoing research, and reflections on advancements in the field.

2. General Requirements

• Letters should be concise and well-argued, with a maximum of 800 words, excluding references.

• Up to 5 references are allowed, cited in [specify  AMA].

• A maximum of 2 authors is permitted.

  Authors

  • Listed in order of contribution.
  • Include full academic or professional affiliation for each author.
  • Provide the ORCID iD for each author.

• Tables and figures are not allowed.

3. Document Structure Letters should follow this structure:

• Title: Concise and representative of the content.

• Main Text: Development of the opinion, critique, or commentary.

• Conclusion: Final reflection or call to action.

• References: Standardized and up-to-date format.

4. Review and Publication Process

• All letters will be reviewed by the Editorial Committee.

• The review will assess relevance, academic rigor, and adherence to editorial standards.

• The publication of a letter does not imply endorsement by the journal.

• The journal reserves the right to edit content for clarity and accuracy.

5. Declarations and Responsibilities

• Authors must disclose any potential conflicts of interest.

• If a letter critiques a published article, the original authors may respond in the same section.

• The opinions expressed are solely the responsibility of the authors.

6. Submission and Format

• Letters must be submitted through the journal's submission system in Word or PDF format.

• Authors must include their contact information and institutional affiliation.

Supplements

SUPPLEMENT

Submission Guidelines

• Supplements must be prepared and submitted in accordance with the Revista Alergia México Author Guidelines. Manuscripts that do not adhere to these guidelines will be returned for revision before entering the review process. The editorial office will not process any companion articles until all related manuscripts have been received.

  Prior invitation is not required for supplements. Interested parties must formally request approval from the journal’s editorial committee, providing a detailed justification that includes the motivation, relevance, and significance of the supplementary material. Once the proposal is reviewed and accepted, the guest editor and contributing authors will be invited to submit their manuscripts through the Revista Alergia México submission platform.

  If the supplement includes systematic reviews or meta-analyses, authors should follow guidelines such as PRISMA (https://www.prisma-statement.org//documents/PRISMA_2020_checklist.docx) or similar frameworks available at the EQUATOR Network (https://www.equator-network.org/library/spanish-resources-recursos-en-espanol/). Manuscripts that do not comply with these standards will not be considered for publication.

  Editorial and Peer Review Process

  All submitted manuscripts will be evaluated by the Editor-in-Chief, a Deputy Editor, or an Associate Editor, along with at least two peer reviewers. The editorial committee will make the final decision regarding the publication of the supplement.

  Revista Alergia México follows a double-blind peer review process managed by the Editor-in-Chief or an Associate Editor. Each article in the supplement is reviewed by at least two external experts. The editorial board reserves the right to accept, reject, or request revisions for individual articles or the entire supplement. The editorial office will inform the Guest Editor or Coordinator of the final decision. Once a supplement is accepted, it is scheduled for publication, and changes to the publication date cannot be accommodated.

  Disclosure and Conflict of Interest

  Each supplement must include a disclosure statement specifying sources of funding. Authors must declare any financial relationships with the sponsor, manufacturers of related products, or competing products mentioned in their manuscripts. Each manuscript must indicate any external support received. The role of medical writers or editors must be explicitly acknowledged, including their affiliations and funding sources.

  If the sponsor has a financial interest in any product mentioned directly or indirectly in the supplement, this relationship must be disclosed. All funding and sponsorship details will be published alongside each article and summarized on the main supplement page.

  Publication of a supplement does not imply endorsement or sponsorship by Revista Alergia México or the Mexican College of Clinical Immunology and Allergy. A disclaimer will be included in both print and electronic versions of the supplement.

  Copyright and Editorial Costs

  Articles published in supplements are subject to the same copyright policies as regular articles in Revista Alergia México. For details on editorial costs and fees, please refer to: https://revistaalergia.mx/ojs/index.php/ram/fees.

  Supplement Development Process

  Revista Alergia México follows the U.S. National Library of Medicine and The International Committee of Medical Journal Editors (ICMJE)  recommendations for supplement publication, available at: https://www.nlm.nih.gov/pubs/factsheets/supplements.html.

  https://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/supplements-theme-issues-and-special-series.html

• To ensure timely publication, supplements require collaboration between the sponsor’s medical/scientific advisor and the journal’s editorial committee. The supplement development process includes:

  1. Initial Discussion: A formal call to outline the proposed supplement, expected content, submission deadlines, peer review procedures, and other relevant details.

  2. Ongoing Editorial Oversight: Regular status meetings, at the editorial board's discretion, with mandatory updates at key milestones:

     • Receipt of all manuscripts.

     • Completion of peer review, with feedback sent to authors for revisions.

  3. Editorial Timelines:

     • Formatting checks, peer review, editorial revisions, and final production typically take 2-4 months before publication.

   

Brief Report

BRIEF RESEARCH ARTICLE

Presents new findings or a new interpretation of original diagnostic or therapeutic allergy /immunology research
findings: new procedures, techniques, or devices are included. Statistical analysis is required.
The Brief Research Article should be a maximum of 2000 words from introduction to discussion.
The recommendations for the structure and content of each section from introduction to
discussion are the same as for the Full Research Article with the following number of words per
section:
• Abstract: 200 words maximum, unstructured
• Introduction: 200 to 300 words
• Material and methods: 400 to 600 words
• Results: 400 to 600 words
• Discussion: 600 to 800 words
• References: maximum 15
• Table: maximum 1
• Figures: maximum 4
Write the discussion in 5 paragraphs. In the first, paragraph, present the result and new findings (main
message) of the study. In the last paragraph, include a subtitle “Conclusion”. Draw a conclusion based
on the main result and new knowledge (main message) of the study and its implications, and/or
recommendations for future studies.
Keywords: include 4 to 6 corresponding to the terms of the MeSH (Medical Subject Headings) of
Index Medicus/ Medline, available at: https://www.ncbi.nlm.nih.gov/mesh.

Abstract

ABSTRACT

1. Scope and Objective
The "Abstracts or Free Papers" section is dedicated to publishing summaries of original research in any scientific discipline relevant to the journal. Its goal is to facilitate the dissemination and access to the latest scientific findings in a concise and structured format.

2. Language and Format
Abstracts must be submitted in both Spanish and English. The recommended maximum length is 250 words per language.

3. Abstract Structure
Each abstract must include the following sections:

• Title (concise and representative of the study)
• Authors (full name, institutional affiliation, ORCID ID, and contact email of the corresponding author)
• Introduction (brief background and study objective)
• Methodology (study design, participants, methods, and data analysis)
• Results (key findings)
• Conclusions (implications and contributions of the study)
• Keywords (3 to 6 terms)

4. Evaluation Criteria
Abstracts will be peer-reviewed through a double-blind evaluation process. The review will consider:

• Relevance and originality
• Clarity of writing
• Methodological soundness
• Contribution to the scientific field

5. Publication Guidelines

• The originality of the work must be ensured, avoiding plagiarism or self-plagiarism.
• Any funding or conflicts of interest must be disclosed in a note at the end of the abstract.
• It is recommended to follow international writing and style standards such as AMA or Vancouver, as applicable.

Respiratory Allergy

RESPIRATORY ALLERGY

The Respiratory Allergy section of Revista Alergia México publishes high-quality scientific contributions related to respiratory allergies, including original articles, reviews, clinical guidelines, position papers, clinical case reports, and consensus documents. Submissions must comply with international editorial, methodological, and ethical standards, as well as the journal’s general policies for each type of article.

This section welcomes research and analysis on epidemiology, diagnosis, management, treatment, prevention, and emerging trends in respiratory allergies, including asthma, allergic rhinitis, hypersensitivity pneumonitis, and other respiratory allergic conditions. Manuscripts should be supported by robust scientific evidence and contribute to the advancement of knowledge in the field.

All submitted articles undergo double-blind peer review, ensuring an impartial evaluation by experts in the subject. Authors must adhere to ethical publication guidelines, including those established by the Committee on Publication Ethics (COPE) (https://publicationethics.org).

For detailed submission requirements, please refer to the general section policies of each article type in Revista Alergia México.

Skin allergy

SKIN ALLERGY 

The Skin Allergy section of Revista Alergia México publishes high-quality scientific contributions on allergic skin diseases, including original articles, reviews, clinical guidelines, position papers, consensus documents, and clinical case reports. All submissions must adhere to international editorial, methodological, and ethical standards, as well as the journal’s general policies for each type of article.

This section welcomes research and clinical analysis on atopic dermatitis, urticaria, contact dermatitis, drug allergies, and other skin-related allergic conditions. Manuscripts should provide scientific evidence and clinical relevance, contributing to the understanding, diagnosis, and management of allergic skin diseases.

All submitted articles undergo double-blind peer review, ensuring an objective evaluation by experts in the field. Authors must comply with ethical publication guidelines, including those established by the Committee on Publication Ethics (COPE) (https://publicationethics.org).

For detailed submission requirements, please refer to the general policies of each article type in Revista Alergia México.

Food Allergy

FOOD ALLERGY

The Food Allergy section of Revista Alergia México publishes high-quality scientific contributions related to food allergies, including original articles, reviews, clinical guidelines, position papers,clinical case reports and consensus documents. Submissions must comply with international editorial, methodological, and ethical standards, as well as the journal’s general policies for each type of article.

This section welcomes research and analysis on epidemiology, diagnosis, management, treatment, prevention, and emerging trends in food allergies. Manuscripts should be supported by robust scientific evidence and contribute to the advancement of knowledge in the field.

All submitted articles undergo double-blind peer review, ensuring an impartial evaluation by experts in the subject. Authors must adhere to ethical publication guidelines, including those established by the Committee on Publication Ethics (COPE) (https://publicationethics.org).

For detailed submission requirements, please refer to the general section  policies of each article type in Revista Alergia México.

Immunology and Immunodeficiency

Immunology and Immunodeficiency 

The Immunology and Immunodeficiency section of Revista Alergia México publishes high-quality scientific contributions on immune system disorders, including original articles, reviews, clinical guidelines, position papers, consensus documents, and clinical case reports. All submissions must comply with international editorial, methodological, and ethical standards, as well as the journal’s general policies for each article type.

This section welcomes research and clinical studies on primary and secondary immunodeficiencies, autoimmune diseases, immune dysregulation syndromes, immunotherapy, and advances in diagnostic and therapeutic approaches. Manuscripts should provide scientific evidence and clinical relevance, contributing to the understanding, diagnosis, and management of immune-related conditions.

All submitted articles undergo double-blind peer review, ensuring an objective evaluation by experts in the field. Authors must adhere to ethical publication guidelines, including those established by the Committee on Publication Ethics (COPE) (https://publicationethics.org).

For detailed submission requirements, please refer to the general policies of each article type in Revista Alergia México.

Environmental allergies

Environmental allergies

The Environmental Allergies section of Revista Alergia México publishes high-quality scientific contributions related to allergic diseases triggered by environmental factors, including original articles, reviews, clinical guidelines, position papers, clinical case reports, and consensus documents. Submissions must comply with international editorial, methodological, and ethical standards, as well as the journal’s general policies for each type of article.

This section welcomes research and analysis on epidemiology, diagnosis, management, treatment, prevention, and emerging trends in environmental allergies, including pollen allergies, mold allergies, dust mite allergies, air pollution-related allergic conditions, and other environmental hypersensitivities. Manuscripts should be supported by robust scientific evidence and contribute to the advancement of knowledge in the field.

All submitted articles undergo double-blind peer review, ensuring an impartial evaluation by experts in the subject. Authors must adhere to ethical publication guidelines, including those established by the Committee on Publication Ethics (COPE) (https://publicationethics.org).

For detailed submission requirements, please refer to the general section policies of each article type in Revista Alergia México.

Miscellaneous

MISCELLANEOUS

The Miscellaneous Allergies section of Revista Alergia México publishes high-quality scientific contributions on allergic conditions that do not fall under other specific sections. This includes, but is not limited to, ocular and digestive allergies. The section welcomes original articles, reviews, clinical guidelines, position papers, clinical case reports, and consensus documents. Submissions must adhere to international editorial, methodological, and ethical standards, as well as the journal’s general policies for each type of article.

This section encourages research and analysis on epidemiology, diagnosis, management, treatment, prevention, and emerging trends in various allergic diseases, particularly those affecting the ocular and digestive systems. Topics include allergic conjunctivitis, eosinophilic esophagitis, food-protein induced enterocolitis syndrome (FPIES), and other gastrointestinal allergic disorders. Manuscripts should be supported by robust scientific evidence and contribute to the advancement of knowledge in the field.

All submitted articles undergo a double-blind peer review process, ensuring an impartial evaluation by subject matter experts. Authors must adhere to ethical publication guidelines, including those established by the Committee on Publication Ethics (COPE) (https://publicationethics.org).

For detailed submission requirements, please refer to the general section policies of each article type in Revista Alergia México.